Unsanctifying the sanctuary: challenges and opportunities with brain metastases
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Unsanctifying the sanctuary: challenges and opportunities with brain metastases
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 17, Issue 5, Pages 639-651
Publisher
Oxford University Press (OUP)
Online
2015-04-06
DOI
10.1093/neuonc/nov023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cyclophosphamide Enhances Human Tumor Growth in Nude Rat Xenografted Tumor Models
- (2015) Yingjen Jeffrey Wu et al. NEOPLASIA
- On demand Gamma-Knife strategy can be safely combined with BRAF inhibitors for the treatment of melanoma brain metastases
- (2014) C. Gaudy-Marqueste et al. ANNALS OF ONCOLOGY
- REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours
- (2014) C. Lévy et al. ANNALS OF ONCOLOGY
- Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study
- (2014) H. Bonnefoi et al. ANNALS OF ONCOLOGY
- Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
- (2014) I. E. Krop et al. ANNALS OF ONCOLOGY
- TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases
- (2014) Carey Anders et al. BREAST CANCER RESEARCH AND TREATMENT
- Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of central nerve system metastases from non-small cell lung cancer
- (2014) Jingze Zhang et al. CANCER LETTERS
- Abstract OT1-1-11: TBCRC 022: Phase II Trial of Neratinib for Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast cancer and Brain Metastases
- (2014) RA Freedman et al. CANCER RESEARCH
- αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer
- (2014) Anna Sophie Berghoff et al. CLINICAL & EXPERIMENTAL METASTASIS
- Laser interstitial thermal therapy in treatment of brain tumors – the NeuroBlate System
- (2014) Alireza M Mohammadi et al. Expert Review of Medical Devices
- Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases
- (2014) Anna Sophie Berghoff et al. HISTOPATHOLOGY
- BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib
- (2014) Sara D. Robinson et al. LUNG CANCER
- Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question
- (2014) M. Nasseri et al. NEURO-ONCOLOGY
- Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study
- (2014) Aki Morikawa et al. NEURO-ONCOLOGY
- Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma
- (2014) Pierina Navarria et al. RADIOTHERAPY AND ONCOLOGY
- Diffusion-weighted MRI characteristics of the cerebral metastasis to brain boundary predicts patient outcomes
- (2014) Rasheed Zakaria et al. BMC MEDICAL IMAGING
- First assessment of whole-brain radiation therapy combined with pemetrexed-based chemotherapy in non-small-cell lung carcinoma
- (2013) Cyrus Chargari et al. ANTI-CANCER DRUGS
- In vivo animal models for studying brain metastasis: value and limitations
- (2013) Inderjit Daphu et al. CLINICAL & EXPERIMENTAL METASTASIS
- Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy
- (2013) Y. Kienast et al. CLINICAL CANCER RESEARCH
- A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320
- (2013) Paul W. Sperduto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- High-Resolution Steady-State Cerebral Blood Volume Maps in Patients with Central Nervous System Neoplasms Using Ferumoxytol, a Superparamagnetic Iron Oxide Nanoparticle
- (2013) Csanad G Varallyay et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer
- (2013) James W. Welsh et al. JOURNAL OF CLINICAL ONCOLOGY
- Pemetrexed and cisplatin combination with concurrent whole brain radiotherapy in patients with brain metastases of lung adenocarcinoma: a single-arm phase II clinical trial
- (2013) Xiao-xiao Dinglin et al. JOURNAL OF NEURO-ONCOLOGY
- Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases
- (2013) Priya Kumthekar et al. JOURNAL OF NEURO-ONCOLOGY
- Breast cancer brain metastases responding to primary systemic therapy with T-DM1
- (2013) Rupert Bartsch et al. JOURNAL OF NEURO-ONCOLOGY
- Editorial: Glioblastoma multiforme and laser interstitial thermal therapy
- (2013) J. Bradley Elder et al. JOURNAL OF NEUROSURGERY
- Which drug, and when, for patients with BRAF-mutant melanoma?
- (2013) Sekwon Jang et al. LANCET ONCOLOGY
- Investigation of the diffusion abnormality index as a new imaging biomarker for early assessment of brain tumor response to radiation therapy
- (2013) R. Farjam et al. NEURO-ONCOLOGY
- Invasion patterns in brain metastases of solid cancers
- (2013) Anna S. Berghoff et al. NEURO-ONCOLOGY
- Melanoma Brain Metastases: an Unmet Challenge in the Era of Active Therapy
- (2013) Vikram Gorantla et al. Current Oncology Reports
- Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases
- (2012) Thomas Spanberger et al. CLINICAL & EXPERIMENTAL METASTASIS
- Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with 18F-ML-10
- (2012) Aaron M. Allen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier
- (2012) Leslie L Muldoon et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Ferumoxytol in clinical practice: Implications for MRI
- (2012) Brendan J. McCullough et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model
- (2012) Y. Jeffrey Wu et al. JOURNAL OF NEURO-ONCOLOGY
- Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis
- (2012) N. Galldiks et al. JOURNAL OF NUCLEAR MEDICINE
- Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial
- (2012) Anna Maria Di Giacomo et al. LANCET ONCOLOGY
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
- (2012) Georgina V Long et al. LANCET ONCOLOGY
- Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
- (2012) Thomas Bachelot et al. LANCET ONCOLOGY
- Perspective: The right trials
- (2012) Patricia S. Steeg NATURE
- Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT
- (2012) Ferdinando Calabria et al. NUCLEAR MEDICINE COMMUNICATIONS
- Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
- (2012) D. P. Kodack et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pseudoprogression of Glioblastoma after Chemo- and Radiation Therapy: Diagnosis by Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging with Ferumoxytol versus Gadoteridol and Correlation with Survival
- (2012) Seymur Gahramanov et al. RADIOLOGY
- The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
- (2011) Steven Eric Finkelstein et al. Clinical & Developmental Immunology
- Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER
- (2011) A. M. Brufsky et al. CLINICAL CANCER RESEARCH
- Brain Metastases as the Primary Site of Relapse in Two Randomized Phase III Pemetrexed Trials in Advanced Non–Small-Cell Lung Cancer
- (2011) Waldo Ortuzar et al. Clinical Lung Cancer
- Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)
- (2011) Gianfranco A. Pesce et al. EUROPEAN JOURNAL OF CANCER
- Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases
- (2011) Paul W. Sperduto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Quantitative Evaluation of the Impact of Active Efflux by P-Glycoprotein and Breast Cancer Resistance Protein at the Blood-Brain Barrier on the Predictability of the Unbound Concentrations of Drugs in the Brain Using Cerebrospinal Fluid Concentration as a Surrogate
- (2011) H. Kodaira et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer
- (2011) Kunal S. Taskar et al. PHARMACEUTICAL RESEARCH
- Chemoprevention for Brain Metastases
- (2011) Van A. Trinh et al. Current Oncology Reports
- Current Treatment Strategies for Brain Metastasis and Complications From Therapeutic Techniques
- (2010) Christopher S. Platta et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Capturing Changes in the Brain Microenvironment during Initial Steps of Breast Cancer Brain Metastasis
- (2010) Mihaela Lorger et al. AMERICAN JOURNAL OF PATHOLOGY
- Diagnostic Value of Peritumoral Minimum Apparent Diffusion Coefficient for Differentiation of Glioblastoma Multiforme From Solitary Metastatic Lesions
- (2010) Eun Ja Lee et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine
- (2010) G. Metro et al. ANNALS OF ONCOLOGY
- Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
- (2010) P. R. Lockman et al. CLINICAL CANCER RESEARCH
- Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or Erlotinib
- (2010) S. Heon et al. CLINICAL CANCER RESEARCH
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
- (2010) E C Dijkers et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis
- (2010) Laura L. Horky et al. JOURNAL OF NEURO-ONCOLOGY
- Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models
- (2010) L. L. Muldoon et al. NEURO-ONCOLOGY
- A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients
- (2010) J. Wang et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of the organ microenvironment in brain metastasis
- (2010) Isaiah J. Fidler SEMINARS IN CANCER BIOLOGY
- Response Assessment in Neuro-Oncology
- (2010) Eudocia C. Quant et al. Current Oncology Reports
- Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
- (2009) N. U. Lin et al. CLINICAL CANCER RESEARCH
- Cell adhesion and signaling networks in brain neurovascular units
- (2009) Joseph H McCarty CURRENT OPINION IN HEMATOLOGY
- The Effect of Early Detection of Occult Brain Metastases in HER2-Positive Breast Cancer Patients on Survival and Cause of Death
- (2009) Anna Niwińska et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation
- (2009) Ho-Taek Song et al. Journal of Translational Medicine
- Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis
- (2009) Jeong-Eun Kim et al. LUNG CANCER
- Real-time imaging reveals the single steps of brain metastasis formation
- (2009) Yvonne Kienast et al. NATURE MEDICINE
- Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
- (2009) Rafael Rosell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of a Preclinical Model of Spontaneous Human Melanoma Central Nervous System Metastasis
- (2008) W. Cruz-Munoz et al. CANCER RESEARCH
- Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2008) Nancy U. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After Radiotherapy
- (2008) Y. Terakawa et al. JOURNAL OF NUCLEAR MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started